Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

被引:0
|
作者
Majd Issa
Brett G. Klamer
Nikol Mladkova
Georgios I. Laliotis
Vidhya Karivedu
Priyanka Bhateja
Chase Byington
Khaled Dibs
Xueliang Pan
Arnab Chakravarti
John Grecula
Sachin R. Jhawar
Darrion Mitchell
Sujith Baliga
Matthew Old
Ricardo L. Carrau
James W. Rocco
Dukagjin M. Blakaj
Marcelo Bonomi
机构
[1] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Medical Oncology
[2] The Ohio State University,Center for Biostatistics, Department of Biomedical Informatics
[3] The Ohio State University Wexner Medical Center,Division of Radiation Oncology
[4] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center and Department of Oncology
[5] The Ohio State University Wexner Medical Center,Department of Otolaryngology
来源
BMC Cancer | / 22卷
关键词
Head and neck cancer; Head and neck squamous cell carcinoma; Immunotherpay; Immune checkpoint inhibitors; Survival in head and neck cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] A novel seven-miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients
    Lu, Le
    Wu, Yufan
    Feng, Min
    Xue, Xiaofeng
    Fan, Yuan
    MOLECULAR MEDICINE REPORTS, 2019, 20 (05) : 4340 - 4348
  • [32] Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
    Bila, Michel
    Franken, Amelie
    Van Dessel, Jeroen
    Garip, Melisa
    Meulemans, Jeroen
    Willaert, Robin
    Hoeben, Ann
    Vander Poorten, Vincent
    Clement, Paul M.
    ORAL ONCOLOGY, 2024, 149
  • [33] Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma
    Pestana, Roberto Carmagnani
    Becnel, Melody
    Rubin, Maria Laura
    Torman, Danice K.
    Crespo, James
    Phan, Jack
    Hanna, Ehab
    Bell, Diana
    Glisson, Bonnie S.
    Johnson, Jason M.
    Lee, J. Jack
    Ferrarotto, Renata
    ORAL ONCOLOGY, 2020, 101
  • [34] Prognostic implications across histological subtypes of head and neck squamous cell carcinoma: An update
    Goncalves, Moises Willian Aparecido
    Lima-Souza, Reydson Alcides de
    Ribeiro-de-Assisa, Maria Clara Falcao
    Cattan, Marcelo Elias Schempf
    Egal, Erika Said Abu
    Altemani, Albina
    Mariano, Fernanda Viviane
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2025, 126 (06)
  • [35] Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
    Wang, Hui-Ching
    Yeh, Tsung-Jang
    Chan, Leong-Perng
    Hsu, Chin-Mu
    Cho, Shih-Feng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 22
  • [36] Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck
    Hall, SF
    Groome, PA
    Rothwell, D
    Dixon, PF
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1999, 21 (01): : 30 - 38
  • [37] Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy
    Scarini, Joao Figueira
    Lavareze, Luccas
    de Lima-Souza, Reydson Alcides
    Emerick, Carolina
    Goncalves, Mayara Trevizol
    Figueiredo-Maciel, Tayna
    Vieira, Gustavo de Souza
    Kimura, Talita de Carvalho
    de Sa, Raisa Sales
    Aquino, Iara Goncalves
    Fernandes, Patricia Maria
    Kowalski, Luiz Paulo
    Altemani, Albina
    Mariano, Fernanda Viviane
    Abu Egal, Erika Said
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180
  • [38] Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitors
    Bonnefin, C.
    Schneider, S.
    Gerard, E.
    Dutriaux, C.
    Ferte, T.
    Prey, S.
    Guicheney, M.
    Ducharme, O.
    Pedeboscq, S.
    Beylot-Barry, M.
    Pham-Ledard, A.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [39] High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors
    Chalker, Cameron
    Santana-Davila, Rafael
    Voutsinas, Jenna M.
    Wu, Qian
    Hwang, Victoria
    Baik, Christina S.
    Lee, Sylvia
    Barber, Brittany
    Futran, Neal D.
    Houlton, Jeffrey J.
    Laramore, George E.
    Liao, Jay Justin
    Parvathaneni, Upendra
    Martins, Renato G.
    Eaton, Keith D.
    Rodriguez, Cristina P.
    JOURNAL OF PALLIATIVE MEDICINE, 2022, 25 (04) : 614 - 619
  • [40] Chromosomal breakpoints in a cohort of head and neck squamous cell carcinoma patients
    Ribeiro, I. P.
    Carreira, I. M.
    Esteves, L.
    Caramelo, F.
    Liehr, T.
    Melo, J. B.
    GENOMICS, 2020, 112 (01) : 297 - 303